UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM
(Amendment No. 1)
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported):
(Exact Name of Registrant as Specified in Charter)
(State or Other Jurisdiction | (Commission File Number) | (IRS Employer | ||
of Incorporation) | Identification No.) |
(Address of Principal Executive Offices) | (Zip Code) |
Registrant’s telephone number, including
area code: (
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Securities registered pursuant to Section 12(b) of the Act:
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.
Emerging growth
company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Securities Exchange Act of 1934. ¨
Explanatory Note
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On December 22, 2021, the Compensation Committee of the Board of Directors of Silicon Laboratories approved the following compensation for Mr. Johnson effective upon his promotion on January 2, 2022: an annual base salary of $650,000 and an annual target bonus as a percentage of his base salary of 130%. The Compensation Committee also approved a promotional grant of 25,014 performance stock units (“PSUs”). The terms of the PSUs are set forth in the Performance Stock Units Grant Notice and Global PSU Award Agreement included as Exhibit 10.1 to this Form 8-K/A. The Compensation Committee also approved, and the Company entered into, the CEO Severance Agreement with Mr. Johnson with an effective date of January 2, 2022 in the form attached as Exhibit 10.1 to the Form 8-K filed on May 17, 2021.
Item 9.01. Financial Statements and Exhibits
(d) Exhibits.
10.1 | Silicon Laboratories Inc. Form of Performance Stock Units Grant Notice and Global PSU Award Agreement under Registrant’s 2009 Stock |
Incentive Plan, as amended and restated |
104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
SILICON LABORATORIES INC. | ||
December 22, 2021 | /s/ John C. Hollister | |
Date | John C. Hollister | |
Senior
Vice President and Chief Financial Officer | ||
(Principal Financial Officer) |